Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Biological and therapeutic significance of targeting NLRP3 inflammasome in the brain and the current efforts to develop brain-penetrant inhibitors.
Journal: Advances in pharmacology (San Diego, Calif.)
Published: February 10, 2025
Functional Characterization of an Arylsulfonamide-Based Small-Molecule Inhibitor of the NLRP3 Inflammasome.
Journal: ACS chemical neuroscience
Published: September 19, 2024
Design and Discovery of Novel NLRP3 Inhibitors and PET Imaging Radiotracers Based on a 1,2,3-Triazole-Bearing Scaffold.
Journal: Journal of medicinal chemistry
Published: December 27, 2023
A patent review of NLRP3 inhibitors to treat autoimmune diseases.
Journal: Expert opinion on therapeutic patents
Published: July 20, 2023
Engineered Substrate for Cyclooxygenase-2: A Pentapeptide Isoconformational to Arachidonic Acid for Managing Inflammation.
Journal: Journal of medicinal chemistry
Published: June 28, 2019
Tailoring the Substitution Pattern on 1,3,5-Triazine for Targeting Cyclooxygenase-2: Discovery and Structure-Activity Relationship of Triazine-4-Aminophenylmorpholin-3-one Hybrids that Reverse Algesia and Inflammation in Swiss Albino Mice.
Journal: Journal of medicinal chemistry
Published: August 11, 2018
Showing 1-6 of 6
Last Updated: 09/26/2026